ExploreWatchlistsPricing
  1. JP-listed companies
  2. VITAL KSK HOLDINGS,INC.
  3. Financials
  4. Stockholders' equity

VITAL KSK HOLDINGS,INC. (3151)

Market cap
¥78B
P/E ratio
9.8x
Vital KSK Holdings distributes pharmaceuticals to hospitals, pharmacies and veterinary practices while operating community pharmacies and healthcare services across Japan.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 2025107,306+1.29%
Mar 31, 2024105,940+5.77%
Mar 31, 2023100,165+0.12%
Mar 31, 2022100,041-3.73%
Mar 31, 2021103,916+6.91%
Mar 31, 202097,198+0.42%
Mar 31, 201996,788-1.69%
Mar 31, 201898,447+9.38%
Mar 31, 201790,007+5.57%
Mar 31, 201685,261+9.02%
Mar 31, 201578,208+15.75%
Mar 31, 201467,566

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat